Dogwood Therapeutics, Inc.
Statements
Cash Flow
Dogwood Therapeutics, Inc. (DWTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -16 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -1.2 | -2.1 | -3.9 | -16 | -11 | -4.9 | -8.8 | -16 | |
| – | – | – | – | – | 0.0 | 0.0 | 0.0 | |
| – | – | 7.4 | 0.3 | 0.6 | 0.6 | 0.5 | 0.4 | |
| 0.9 | 0.3 | -1.0 | -0.1 | 0.2 | -0.2 | -0.6 | -0.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | – | 3.8 | – | |
| – | – | 0.1 | 0.0 | – | – | – | – | |
| – | – | – | -0.3 | – | 0.0 | 0.0 | 0.0 | |
| – | – | – | 0.0 | – | 0.0 | 15 | 3.0 | |
| 1.2 | 2.4 | 33 | -0.1 | 4.5 | 1.2 | 17 | 7.3 | |
| 0.0 | 0.3 | 29 | -16 | -7.0 | -3.7 | 12 | -8.3 | |
| -1.2 | -2.1 | -3.9 | -16 | -11 | -4.9 | -8.8 | -16 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.